Canadian doctors warn health system not sufficient to help with looming mental health crisis
The holidays can be a difficult time of year for many Canadians, especially with the ongoing COVID-19 pandemic making people feel more isolated than ever, and doctors are warning that the therapies available through the Canadian health system is not sufficient to help people with anxiety and other mental health issues. “I can tell you […]
Canadian Early-Stage Pharmaceutical Company, EmpowerPharm Names Dr. Murray B. Stein Senior Medical Consultant
EmpowerPharm Inc., the first wholly Canadian-owned and operated pharmaceutical company established in recent years, is pleased to announce the appointment of Dr. Murray B Stein as Senior Medical Consultant. A pioneer in psychiatry and the treatment of anxiety, Dr. Stein joins an already impressive list of physicians who are advising the early-stage pharmaceutical company as […]
Elected Officials Visit EmpowerPharm’s State-of-the-Art Manufacturing Facility
Our state-of-the-art manufacturing facility is making headlines. Politicians from all three levels of government – municipal, provincial, and federal – are visiting the facility to see the innovation within its walls and to understand how we will bring global business to the city of Burlington. Maryanne Meed Ward, the Mayor of Burlington, and Jane McKenna, […]
Adapting Healthcare Systems for Tomorrow: Panel Discussion
On October 28, EmpowerPharm Co-Founder and Executive Chairman participated in the world-renowned Toronto Global Forum, hosted by the International Economic Forum of the Americas. The COVID-19 pandemic has put an unparalleled strain in the global healthcare and surrounding ecosystems. What can be learned in terms of dealing with future health crises of the same nature? […]
A Made-in-Canada solution can ensure Canadians are prepared for the impending mental health crisis
EmpowerPharm Inc. is developing an innovative prescription CBD therapy that may be a game-changer for treating anxiety Hundreds of thousands of Canadians are facing a mental health crisis due to the far-reaching ripple effects of COVID-19, and one homegrown company is working to ensure support to the country. EmpowerPharm Inc., a wholly Canadian-owned and operated […]
EmpowerPharm Appoints Director of Corporate Reporting
EmpowerPharm is delighted to announce the appointment of Keith Pang as Director of Corporate Reporting Keith is a finance professional with over 20 years of public company experience across a wide range of industries, including pharmaceuticals and manufacturing. In his previous role as Corporate Controller of Cynapsus Therapeutics, he was responsible for building the finance […]
An Interview with Vice-Chairman Jack Kay
Your impressive career in pharmaceutical leadership surely provides you a long-term perspective on the pharmaceutical industry in Canada. What has changed since you first entered the industry? I’m going to go back a little before I entered the industry to describe how I arrived there in the first place. Professionally, I am a registered psychiatric […]
Pioneers of Canada’s pharmaceutical industry join forces to tackle the mental health pandemic expected in the wake of COVID
TORONTO, Sept. 9, 2020 /CNW/ – The former heads of Canada’s most recognized domestic pharmaceutical companies have united to help combat the mental health crisis expected to impact Canadians long after the COVID-19 pandemic. EmpowerPharm Inc., the first wholly Canadian owned and operated pharmaceutical company established in Canada in recent years, is ushering in a new era for […]
EmpowerPharm Appoints Director of Engineering
EmpowerPharm is delighted to announce the appointment of Colin Staunton as Director of Engineering Colin is a Pharmaceutical and Engineering professional that comes to us with over 15 years’ experience in the industry. Prior to joining EmpowerPharm he was the Engineering Manager at Contract Pharmaceuticals Limited where he crafted his skills in process design, continuous […]
EmpowerPharm adds Director of Clinical Projects
EmpowerPharm is delighted to announce the appointment of Dr. Anat Fields as Director of Clinical Projects to the science team. Dr. Fields received her undergraduate degree in Pharmacy from the Hebrew University in Jerusalem and proceeded to M.Sc. in pharmacology, focusing on the mechanism of action of tricyclic antidepressants. She subsequently completed her Ph.D. at […]